300142.SZ Forward P/E

The Forward P/E of Walvax Biotechnology Co Ltd (300142.SZ) is 25.07.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

300142.SZ Forward P/E - Peers Comparison

Ticker	Name	Value
300601.SZ	Shenzhen Kangtai Biological Products Co Ltd	23.37
2696.HK	Shanghai Henlius Biotech Inc	26.13
1801.HK	Innovent Biologics Inc	215.72
300009.SZ	Anhui Anke Biotechnology Group Co Ltd	14.28
600161.SS	Beijing Tiantan Biological Products Corp Ltd	21.90
603087.SS	Gan & Lee Pharmaceuticals	46.91
000403.SZ	Pacific Shuanglin Bio-pharmacy Co Ltd	16.55
688363.SS	Bloomage Biotechnology Corp Ltd	38.72
300841.SZ	Chengdu Kanghua Biological Products Co Ltd	8.58
600201.SS	Jinyu Bio-Technology Co Ltd	25.21
688278.SS	Xiamen Amoytop Biotech Co Ltd	24.54
300294.SZ	China Resources Boya Bio pharmaceutical Group Co Ltd	23.65
300896.SZ	Imeik Technology Development Co Ltd	23.38
300832.SZ	Shenzhen New Industries Biomedical Engineering Co Ltd	21.80
603392.SS	Beijing Wantai Biological Pharmacy Enterprise Co Ltd	133.16
002675.SZ	Yantai Dongcheng Biochemicals Co Ltd	43.74
688166.SS	BrightGene Bio-Medical Technology Co Ltd	84.29
300685.SZ	Amoy Diagnostics Co Ltd	20.31
002252.SZ	Shanghai RAAS Blood Products Co Ltd	16.32
1530.HK	3SBio Inc	11.60
300406.SZ	Beijing Strong Biotechnologies Inc	14.44
688198.SS	Beijing Balance Medical Technology Co Ltd	74.37
002007.SZ	Hualan Biological Engineering Inc	21.76